These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Trends in vitreoretinal surgery--time to stop and think. Leaver PK Br J Ophthalmol; 1999 Apr; 83(4):385-6. PubMed ID: 10434855 [No Abstract] [Full Text] [Related]
9. Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial. de Smet MD; Gandorfer A; Stalmans P; Veckeneer M; Feron E; Pakola S; Kampik A Ophthalmology; 2009 Jul; 116(7):1349-55, 1355.e1-2. PubMed ID: 19447497 [TBL] [Abstract][Full Text] [Related]
10. Safety and complications of ocriplasmin: ocriplasmin, ocriplasmin; oh, how safe art thou? Kim JE JAMA Ophthalmol; 2014 Apr; 132(4):379-80. PubMed ID: 24577332 [No Abstract] [Full Text] [Related]
15. [Effect of enzymatic vitreolysis on the absorption of experimental vitreous hemorrhage. Preliminary report]. Zagórski Z Klin Oczna; 1983 May; 85(5):197-9. PubMed ID: 6316024 [No Abstract] [Full Text] [Related]
16. Pharmacologic Vitreolysis in Vascular Diseases of the Retina. Soliman MK; Agarwal A; Sarwar S; Hanout M; Sadiq MA; Do DV; Nguyen QD Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):60-8. PubMed ID: 26731211 [TBL] [Abstract][Full Text] [Related]
17. How should we release vitreomacular traction: surgically, pharmacologically, or pneumatically? Johnson MW Am J Ophthalmol; 2013 Feb; 155(2):203-205.e1. PubMed ID: 23312439 [No Abstract] [Full Text] [Related]
19. Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Proctor lecture. Machemer R Invest Ophthalmol Vis Sci; 1988 Dec; 29(12):1771-83. PubMed ID: 3056866 [No Abstract] [Full Text] [Related]
20. [Progression of pharmacologic vitreolysis research]. Zhou H; Ye J Zhonghua Yan Ke Za Zhi; 2014 Mar; 50(3):225-9. PubMed ID: 24841819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]